Researchers from the University College Cork have discovered a significant connection between gut microbiota and increased social fear in individuals suffering from social anxiety disorder (SAD). Thisstudy, published in the Proceedings of the National Academy of Sciences, indicates that the composition of the gut microbiota could influence social fear behaviours, opening new potential avenues for treatment.
Millions of people worldwide suffer from social anxiety disorder, a condition characterised by extreme fear or anxiety in social situations. Despite its prevalence, the biological mechanisms underpinning SAD have been elusive. This research builds on existing studies suggesting that the gut microbiota – the trillions of microorganisms residing in our intestines – can impact brain function and behaviour.
Dr Nathaniel Ritz led the research team as they carried out experiments on mice using faecal microbiota transplantation (FMT) from human donors with SAD. By transferring gut microbiota from SAD patients to germ-free mice, the researchers could observe resultant changes in the animals’ behaviour, specifically their responses to social fear stimuli.
The study involved transplanting faecal microbiota from both SAD patients and healthy controls into different groups of mice. Post-transplantation, the mice underwent behavioural tests to measure social fear, sociability, social cognition, and stress-coping behaviours.
A key observation was that mice receiving microbiota from SAD patients exhibited heightened sensitivity to social fear. This was assessed using a social fear conditioning and extinction paradigm, a recognised method for studying social fear in rodents. Mice with SAD microbiota showed a marked reduction in social interaction over several trials, indicating increased sensitivity to social fear stimuli. In contrast, mice that received microbiota from healthy controls did not exhibit such behaviours.
Interestingly, other social behaviours, such as general sociability and preference for social novelty, were unaffected by the SAD microbiota. This specificity suggests that the influence of gut microbiota on behaviour is particularly relevant to social fear, rather than social behaviour broadly.
The researchers also delved into the biological mechanisms behind these behavioural changes. They discovered that mice with SAD microbiota had altered immune responses and hormone levels linked to stress and social behaviour. Notably, there was a reduction in the stress hormone corticosterone and changes in oxytocin levels, a hormone crucial for social bonding and fear responses.
Brain tissue analysis from these mice showed changes in gene expression related to inflammation and immune function. These findings suggest that gut microbiota may affect social fear through its impact on the immune system and hormone signalling pathways.
The study’s results indicate that gut microbiota could be a promising target for new treatments for social anxiety disorder. By modifying the composition of gut microbiota, it might be possible to reduce some of the social fear symptoms associated with SAD. This could involve using probiotics, prebiotics, or even faecal microbiota transplantation as therapeutic strategies.
The research provides compelling evidence that the gut-brain axis is a crucial pathway in the manifestation of social fear. Understanding this role opens up new avenues for treatment, potentially leading to innovative therapies that target the microbiome.
While the study offers promising insights, further research is necessary to fully understand the complex interactions between gut microbiota, the immune system, and the brain. Long-term studies involving human participants will be vital to determining the efficacy and safety of microbiota-based treatments for social anxiety disorder.
